On Tuesday, Shares of HCP, Inc. (NYSE:HCP), loss -2.94% to $39.55.
HCP, declared results for the quarter ended March 31, 2015.
In February 2015, the company began construction on the first phase, $177 million, of The Cove at Oyster Point, a life science development in South San Francisco, California. The first phase comprises two “class A” buildings totaling 253,000 sq. ft. that are predictable to be accomplished in the third quarter of 2016.
In February 2015, the company raised its U.K. HC-One debt investment (“HC-One Facility”) by £108 million to £502 million in conjunction with HC-One’s acquisition of Meridian Healthcare. The HC-One Facility is secured by 303 nursing and residential care homes representing over 13,900 beds in the U.K., primarily located in England and Scotland.
In April 2015, the company converted £174 million of our HC-One Facility to fee ownership in a portfolio of 36 care homes under long term triple-net leases that provide aggregate rent in the first year of £13 million. The contractual rent will enhance annually by the Retail Price Index (“RPI”) and will be reset to fair market rent at the end of lease years 15 and 25. The triple-net leases have initial terms of 30 years with lessee termination options at the end of lease years 15 and 25.
HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry counting sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing.
Shares of Horizon Pharma plc (NASDAQ:HZNP), declined -2.93% to $28.82, during its last trading session.
Horizon Pharma, declared that it will attend and present at the following conferences in May:
- Bank of America Merrill Lynch 2015 Health Care Conference
- Presentation Date: Tuesday, May 12, 2015
- Presentation Time: 4:20 p.m. PT (7:20 p.m. ET)
- 2015 UBS Global Health Care Conference
- Presentation Date: Monday, May 18, 2015
- Presentation Time: 1:00 p.m. ET
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
At the end of Tuesday’s trade, Shares of The New York Times Company (NYSE:NYT), dipped -2.93% to $13.60.
The New York Times Company, declared adjusted diluted earnings per share from ongoing operations of $.11 in the first quarter of 2015 contrast with $.07 in the first quarter of 2014. There was a first-quarter 2015 diluted loss per share from ongoing operations of $.09 contrast with diluted earnings per share of $.02 in the same period of 2014.
Adjusted operating profit grew to $59.2 million in the first quarter of 2015 from $56.6 million in the first quarter of 2014, as broad cost reductions more than offset a decline in revenues. There was an operating loss of $11.1 million in the first quarter of 2015 contrast with an operating profit of $22.1 million in the same period of 2014, driven by special pension charges in this year’s first quarter.
The New York Times Company, together with its auxiliaries, provides news and information for readers and viewers across various media worldwide. The company provides The New York Times (The Times), a daily and Sunday newspapers in the United States accessible in print, online, and through other digital platforms; the International New York Times, an international edition of The Times for global audiences; and NYTimes.com and international.nytimes.com.
Finally, Whiting Petroleum Corp. (NYSE:WLL), ended its last trade with -2.92% loss, and closed at $36.84.
Whiting Petroleum’s production in the first quarter 2015 totaled 15.0 million barrels of oil equivalent (MMBOE), 88% crude oil/natural gas liquids (NGLs). First quarter 2015 production averaged 166,930 barrels of oil equivalent per day (BOE/d). This represents a 3% pro forma enhance over the full fourth quarter 2014.
Non-Core Property Sales
On April 15, 2015, Whiting sold older, conventional, operated and non-operated properties to a private buyer for $108 million. The properties were predominantly assets from Whiting USA Trust I, which reverted to Whiting Petroleum Corporation ownership in January 2015. The effective date of the sale is May 1, 2015 and the sale closed on April 15, 2015. The properties spanned about 4,000 wells, counting several multi-well units, in 187 fields across 14 states. Reserves totaled an estimated 8.2 MMBOE (86% oil) as of the effective date of the sale with estimated remaining 2015 production of 2,200 BOE/d. The sale was consistent with Whiting’s ongoing 2015 plans to sell mature properties with higher LOE per BOE than its core Bakken and Niobrara assets. LOE for the properties averaged about $25.00 per BOE as compared to $6.50 per BOE in the Bakken and $9.00 per BOE in our core Niobrara area.
Whiting Petroleum Corporation, an independent oil and gas company, acquires, explores, develops, and produces crude oil, natural gas liquids, and natural gas in the Rocky Mountains and Permian Basin regions of the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
